Clinical Trial Update: Phase 2a Clinical Trial of ID93+GLA-SE Vaccine in BCG-vaccinated Healthy Healthcare Workers [Phase 2]

View source ↗

Summary

Phase 2a trial update for ID93+GLA-SE vaccine in BCG-vaccinated healthy healthcare workers for tuberculosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• ID93 + GLA-SE vaccine

Snippet

Sponsor: Quratis Inc. | Conditions: Tuberculosis | Phase 2 | Status: UNKNOWN